Drug Pricing

All articles by Drug Pricing

MM+M Podcast 2.8.23: Eisai’s pricing transparency, GAO’s report on ‘gain-of-function’ research and MrBeast’s polarizing video
MM+M Podcast 2.8.23: Eisai’s pricing transparency, GAO’s report on ‘gain-of-function’ research and MrBeast’s polarizing video
MM+M Staff
February 8, 2023
2:30 pm

Marc Iskowitz comments on Eisai’s pricing transparency, Lecia Bushak discusses efforts to strengthen “gain-of-function” oversight, and Jack O’Brien addresses the recent controversy around a MrBeast video.

Inside pharma’s push to amend new drug-pricing law
Inside pharma’s push to amend new drug-pricing law
Marc Iskowitz
February 3, 2023
10:30 am

Novartis CEO and incoming PhRMA board chair Vas Narasimhan says nullifying the Inflation Reduction Act’s nine-year timeline for small molecules tops his agenda.

‘Known unknowns’ make new pricing law a wild card for drug companies
‘Known unknowns’ make new pricing law a wild card for drug companies
Marc Iskowitz
January 30, 2023
5:30 am

The Inflation Reduction Act is the drug industry’s new talking point. Companies are raising awareness of the law’s unintended consequences, while reassuring investors that they can manage through the risk.

California Attorney General sues drugmakers over inflated insulin prices
California Attorney General sues drugmakers over inflated insulin prices
Angela Hart and Samantha Young, KHN
January 13, 2023
2:15 pm

The civil complaint alleges three pharmaceutical companies that control the insulin market are violating California law by unfairly and illegally driving up the cost of the drug

Ascending to Senate HELP committee chair, Bernie Sanders targets high drug prices, ‘cruel and dysfunctional’ healthcare system
Ascending to Senate HELP committee chair, Bernie Sanders targets high drug prices, ‘cruel and dysfunctional’ healthcare system
Lecia Bushak
January 11, 2023
3:26 pm

The Vermont Senator has ambitious goals when he assumes the lead role of the Senate HELP Committee next month.

CMS to announce 10 drugs for Medicare price negotiations on Sept. 1
CMS to announce 10 drugs for Medicare price negotiations on Sept. 1
Jack O'Brien
January 11, 2023
2:00 pm

The agency also released a memo outlining additional details regarding the implementation of the law for interested stakeholders.

ICER: Paxlovid is worth less than initial health benefit price benchmark
ICER: Paxlovid is worth less than initial health benefit price benchmark
Jack O'Brien
December 21, 2022
3:53 pm

The revision was attributed to lower risk of hospitalization among untreated patients and lower relative reduction in hospitalization with Paxlovid.

States challenge Biden to lower drug prices by allowing imports from Canada
States challenge Biden to lower drug prices by allowing imports from Canada
Phil Galewitz, KHN
December 14, 2022
10:51 am

The Biden administration is facing mounting pressure from states to let them import medicine from Canada to help lower prescription drug costs.

Paxlovid has been free so far. Next year, sticker shock awaits.
Paxlovid has been free so far. Next year, sticker shock awaits.
Hannah Recht, KHN
December 7, 2022
3:00 pm

Millions of people who are at the highest risk of severe illness and are least able to afford the drug may have to pay the full price.

See which drug price hikes were unsupported by new clinical evidence
See which drug price hikes were unsupported by new clinical evidence
Jack O'Brien
December 7, 2022
1:46 pm

ICER’s list found that seven of the top 10 drugs with net price hikes had “substantial effects” on the U.S. drug spend.

  • From Our Partners